Optimal phenotypic pre-selection, including genetic or histologic abnormalities in the tumor, or even the presence of additional congenital features as we recently identified in individuals with BUB1 and BUB3 abnormalities,[52] may limit this heterogeneity. This evidence concerns the gene BUB3 and neoplasm.